Dr Penny Kechagioglou

GenesisCare UK

Dr Penny Kechagioglou is a senior clinical oncology consultant with a diverse portfolio of clinical strategy, clinical governance, innovation and research. After qualifying as a doctor in Wales, she completed an internal medicine residency in UK, following which she completed and was awarded a CCT in Clinical Oncology (2010). Has worked as a consultant clinical oncologist in various UK NHS Trusts and has experience in managerial roles such as Chief Medical Officer at Genesis Care UK, Clinical Governance Lead for Oncology/Haematology in the NHS, Vice Chair and member of Research Ethics Committees, NICE Health Technology Assessment Committee member, Specialist advisor for the CQC and the Healthcare Ombudsman. Dr Kechagioglou is a principal investigator and co-investigator in many national and international breast cancer clinical trials and has a medical education portfolio as Senior Clinical Lecturer, Academic mentor, Medical tutor and postgraduate GP Educator. She has completed an MSc in Public Health and an MBA and she is currently working toward a Doctorate in Business Administration.

dont miss

Breast cancer Service of the Future: a service transformation

The Breast Service of the Future is a service transformation project, which aims at combining all elements of excellent cancer care from diagnosis to survivorship. At times of financial and workforce pressures, there should not be any compromise in the quality, efficiency and access to world class cancer care. Cancer care should be patient-focused and individualised, from diagnosis through to surgery, radiotherapy, chemotherapy and surveillance. The presentation will take the audience the why and how this was achieved by a single private organization.

EVEN MORE SEMINARS

  • Dr Penny Kechagioglou: Speaking at the Oncology Convention

    Dr Penny Kechagioglou
    GenesisCare UK

    Breast cancer Service of the Future: a service transformation

  • Professor David Snead: Speaking at the Oncology Convention

    Professor David Snead
    University Hospitals of Coventry and Warwickshire NHS Trust

    Digital Pathology – the scope and potential return on investment.

  • Professor Robert Thomas: Speaking at the Oncology Convention

    Professor Robert Thomas
    Bedford and Addenbrooke's Cambridge University Hospitals

    Evidence based lifestyle strategies after cancer - a research review

  • Maureen (Mo) Beange: Speaking at the Oncology Convention

    Maureen (Mo) Beange
    Vision RT

    Benefits of SGRT for patients receiving radiotherapy for Breast cancer

  • Dr Tony Dhillon: Speaking at the Oncology Convention

    Dr Tony Dhillon
    University of Surrey and Royal Surrey County Hospital

    Immunotherapy and Colon Cancer